Circulating nucleic acids in plasma and serum: Roles in diagnosis and prognosis

Predictive Diagnostics and Personalized Treatment: Dream or Reality

Volumn , Issue , 2009, Pages 31-53

  Gahan, Peter B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Circulating DNA RNA; Diabetes; Diagnosis; Nucleic acid uptake expression; Plasma serum

Indexed keywords

EID: 84892329844     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (141)

1. Mendel P, Métais P (1948) Les acides nucléiques du plasma sanguine chez l'homme. C R Acad. Sci. Paris, 142, 241-243.
2. Watson JD, Crick FH (1953) A Structure for deoxyribose nucleic acid. Nature, 171, 737-738.
3. Wilkins MH, Stokes AR, Wilson HR (1953) Molecular structure of deoxypentose nucleic acids. Nature, 171, 738-740.
4. Sinsheimer RL (1957) First steps toward a genetic chemistry. Science, 125, 1123-1128.
5. Koffler D, Agnello V, Winchester R (1973) The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythrematosus and other diseases. J. Clin. Invest., 52, 198-204.
6. Tan EM, Schur PH, Carr RI, Kunkel HG (1966) Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythrematosus. J. Clin. Invest., 45, 1732-1740.
7. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37, 646-650.
8. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M (1989) Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology, 46, 318-322.
9. Lam NY, Rainer TH, Chan LY, Joynt GM, Lo YM (2003) Time course of early and late changes in plasma DNA in trauma patients. Clin. Chem., 49, 1286-1291.
10. Rainer TH, Lam NY (2006) Circulating nucleic acids and critical illness. Ann. N. Y. Acad. Sci., 1075, 271-277.
11. Geiger S, Holdenrieder S, Stieber P, Hamann GF, Bruening R, Ma J, Nagel D, Seidel D (2007) Nucleosomes as a new prognostic marker in early cerebral stroke. J. Neurology, 254, 617-623.
12. Lo YM, Patel P, Wainscoat JS, Sampietro M, Gillmer MD, Fleming KA (1989) Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet, 2, 1363-1365.
13. Vecchione G, Tomaiuolo M, Sarno M, Colaizzo D, Petraroli R, Matteo M, Greco P, Grandone E, Margaglione M (2008) Fetal identification in maternal plasma by means of short tandem repeats on chromosome X. Ann. N. Y. Acad. Sci., 1137, 148-156.
14. Vainer OB, Katokhin AV, Khustov SM, Vlassov VV, Laktionov PP (2008) A new Y chromosome marker for non-invasive fetal gender determination. Ann. N. Y. Acad. Sci., 1137, 157-161.
15. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem., 45, 184-188.
16. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S (2004) Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem., 50, 1002-1011.
17. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM (2002) Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin. Chem., 48, 2141-2146.
18. Finning K, Martin P, Daniels G (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. N. Y. Acad. Sci., 1022, 119-124.
19. Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, Barry J, Betz J, Franz K, Gold K (2007) A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet, 369, 474-481.
20. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat. Med., 13, 218-223.
21. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S (2005) Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA, 293, 843-849.
22. Zhang J, Fidler C, Murphy MF, Chamberlain PF, Sargent IL, Redman CW, Hjelm NM, Wainscoat JS, Lo YM (1998) Determination of fetal RhD status by maternal plasma DNA analysis. Ann. N. Y. Acad. Sci., 906, 153-155.
23. Papasavva T, Kalikas I, Kyrri A, Kleanthous M (2006) Noninvasive prenatal diagnotic assay for the detection of ß-thalassemia. Ann. N. Y. Acad. Sci., 1075, 148-153.
24. Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer: a survey. Biochim. Biophys. Acta, 1775, 181-232.
25. Rykova EY, Bryzgunova OE, Skvortsova TE, Tamkovich TN, Senin IN (2006) Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Ann. N. Y. Acad. Sci., 1075, 328-333.
26. Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H (2003) Degradation of chromosomal DNA during apoptosis. Cell Death Differ., 10, 108-116.
27. Holdenrieder S, Stieber P (2004) Apoptotic markers in cancer. Clin. Biochem., 37, 605-617.
28. Nagata S (2005) DNA degradation in development and programmed cell death. Ann. Rev. Immunol., 23, 853-875.
29. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmeyer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res., 61, 1659-1665.
30. Pisetsky DS (2004) The immune response to cell death in SLE. Autoimmun. Rev., 3, 500-504.
31. Ren Y, Savill J (1998) Apoptosis: the importance of being eaten. Cell Death Differ, 5, 563-568.
32. van der Vaart M, Pretorius PJ (2007) The origin of circulating free DNA. Clin. Chem., 53, 2215.
33. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IeM (2001) Increased plasma DNA integrity in cancer patients. Cancer Res., 63, 3966-3968.
34. Georgiou CD, Patsoukis N, Papapostolou I (2005) Assay for the quantification of small-sized fragmented genomic DNA. Anal. Biochem., 339, 223-230.
35. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM (2003) Molecular characterization of circulating EBV DNA in the plasma of EBV patients. Cancer Res., 63, 2028-2032.
36. Yang HJ, Liu VW, Tsang PC, Yip AM, Tam KF, Wong LC, Ng TY, Ngan HY (2004) Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int. J. Gynecol. Cancer, 14, 903-910.
37. Tamkovich SN, Litvjakov NV, Bryzgunova OE, Rykova EY, Dobrodeev AY, Zavjalov AA, Tusikov SA, Vlassov VV, Cherdyntseva NV, Laktionov PP (2007) Blood cell-surface-bound extracellular DNA level as diagnostics marker in lung cancer. 3rd Internat. Conf. Basic Science for Medicine Sept. 2-8, Russian Academy of Sciences, Siberia, 178.
38. Laktionov PP, Tamkovich SN, Rykova EY, Bryzgunova OE, Starikov AV, Kuznetsova NP, Vlassov VV (2004) Cell-surface-bound nucleic acids: free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann. N. Y. Acad. Sci., 1022, 221-227.
39. Malshakova VS, Pyshnyi DV, Bondar AA, Vlassov VV, Laktionov PP (2008) Isolation and sequencing of short cell-surface-bound DNA. Ann. N. Y. Acad. Sci., 1137, 47-50.
40. Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR (1972) Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc. Natl. Acad. Sci. U.S.A., 69, 1685-1689.
41. Anker P, Stroun M, Maurice PA (1975) Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res., 35, 2375-2382.
42. Olsen I, Harris G (1974) Uptake and release of DNA by lymphoid tissue and cells. Immunology, 27, 973-987.
43. Adams DH, Gahan PB (1982) Stimulated and non-stimulated rat spleen cells release different DNA-complexes. Differentiation, 22, 47-52.
44. Adams DH, Gahan PB (1983) The DNA extruded by rat spleen cells in culture. Int. J. Biochem., 15, 547-552.
45. Ottolenghi E, Hotchkiss RD (1960) Appearance of genetic transforming activity in pneumococcal cultures. Science, 132, 1257-1258.
46. Ottolenghi E, Hotchkiss RD (1962) Release of genetic transforming agent from pneumococcal cultures during growth and disintegration. J. Exp. Med., 116, 491-519.
47. Borenstein S, Ephrati-Elizur E (1969) Spontaneous release of DNA in sequential genetic order by Bacillus subtilis. J. Mol. Biol., 45, 137-152.
48. Stroun M, Gahan PB, Sarid S (1969) Agrobacterium tumefaciens RNA in non-tumerous tomato cells. Biochem. Biophys. Res. Commun., 37, 652-657.
49. Adams DH, Diaz N, Gahan PB (1997) In vitro stimulation by tumour cell media of [3H]-thymidine incorporation by mouse spleen lymphocytes. Cell Biochem. Funct., 15, 119-126.
50. Adams DH, McIntosh AA (1985) Studies on the cytosolic DNA of chick embryo fibroblasts and its uptake by recipient cultured cells. Int. J. Biochem., 17, 1041-1051.
51. Stroun M, Anker P (1972) In vitro synthesis of DNA spontaneously released by bacteria or frog auricles. Biochimie, 54, 1443-1452.
52. Stroun M, Anker P (1972) Nucleic acids spontaneously released by living frog auricles. Biochem. J., 128, 100P-101P.
53. Stroun M, Anker P, Gahan PB, Henri J (1977) Spontaneous release of newly synthesized DNA from frog auricles. Arch. Sci. Genève, 30, 229-241.
54. Anker P, Stroun M (1977) Spontaneous extra-cellular synthesis of DNA released by frog auricles. Arch. Sci. Genève, 30, 263-278.
55. Gahan PB (2003) Messenger DNA in higher plants. Cell Biochem. Function, 21, 207-209.
56. Stroun M (1971) On the nature of the polymerase responsible for the transcription of released bacterial DNA. Biochem. Biophys. Res. Commun., 44, 571-578.
57. Anker P, Stroun M (1972) Abstr. Int. Congr. Cell Biol. Brighton, 3.
58. Anker P, Stroun M, Maurice P (1974) Abstr. Xith Int. Cancer cong. Firenze, 2, 24.
59. Morozkin ES, Babochkina TI, Vlassov VV, Laktionov PP (2008) The effect of protein transport inhibitors on the production of extracellular DNA. Ann. N. Y. Acad. Sci., 1137, 31-35.
60. Gahan PB, Anker P, Stroun M (2008) Metabolic DNA as the origin of spontaneously released DNA? Ann. N. Y. Acad. Sci., 1137, 7-17.
61. Pelc SR (1968) Biological implications of DNA-turnover in higher organisms. Acta Histochem., S8, 41-52.
62. Anker P, Stroun M (1972) Bacterial ribonucleic acid in the frog brain after a bacterial peritoneal infection. Science, 178, 621-623.
63. Stroun M, Anker P (1973) Transcription of spontaneously released bacterial deoxyribonucleic acid in frog auricles. J. Bacteriol., 114, 114-120.
64. Anker P, Jachertz D, Maurice PA, Stroun M (1984) Nude mice injected with DNA released by antigen stimulated human T lymphocytes produce specific antibodies expressing human characteristics. Cell Biochem. Funct., 2, 33-37.
65. Ermakov AV, Kostyuk SV, Konkova MS, Egolina NA, Malinovskaya EM, Veiko NN (2008) Extarcellular DNA fragments: factors of stress signalling between X-irradiated and non-irradiated human lymphocytes. Ann. N. Y. Acad. Sci., 1137, 41-46.
66. Bulicheva N, Fidelina O, Krtumova MN, Neverova M, Bogush A, Bogush M, Roginko O, Veiko N (2008) Effect of cell-free DNA of patients with cardiomyopathy and rDNA on the frequency of contraction of electrically paced neonatal rat ventricular myocytes in culture. Ann. N. Y. Acad. Sci., 1137, 273-277.
67. Skvortsova TE, Vlassov VV, Laktionov PP (2008) Binding and penetration of methylated DNA into primary and transformed human cells. Ann. N. Y. Acad. Sci., 1137, 36-40.
68. Garcia-Olmo DC, Ruiz-Piqueras R, Garcia-Olmo D (2004) Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. Histol. Histopathol., 19, 575-583.
69. Kopreski MS, Benko FA, Kwak LW, Gocke CD (1999) Detection of tumor messenger. RNA in the serum of patients with malignant melanoma. Clin. Cancer Res., 5, 1961-1965.
70. Silva JM, Rodriguez R, Garcia JM, Muñoz C, Silva J, Dominguez G, Provencio M, España P, Bonilla F (2002) Detection of epithelial tumor RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut, 50, 530-534.
71. El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, Godfrey TE (2004) Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem., 50, 564-573.
72. Bai VU, Kaseb A, Tejwani S, Divine GW, Barrack ER, Menon M, Pardee AB, Reddy GP (2007) Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Proc. Natl. Acad. Sci. U.S.A., 104, 2343-2348.
73. Melkonyan HS, Feaver WJ, Meyer E, Scheinker V, Shekhtman EM, Xin Z, Umansky SR (2008) Transrenal nucleic acids: from proof to principle to clinical tests: problems and solutions. Ann. N. Y. Acad. Sci., 1137, 73-81.
74. Dasí F, Lledó S, García-Granero E, Ripoll R, Marugán E, Tormo M, García-Conde J, Aliño SF (2001) Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest., 81, 767-769.
75. Hasselman DO, Rappl G, Tilgen W, Reinhold U (2001) Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem., 47, 1488-1489.
76. Stroun M, Anker P, Maurice P, Gahan PB (1977) Circulating nucleic acids in higher organisms. Int. Rev. Cytol., 51, 1-48.
77. Stroun M, Anker P, Beljanski M, Henri J, Lederrey C, Ojha M, Maurice P (1978) Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res., 38, 3546-3554.
78. Stroun M (1971) On the nature of the polymerase responsible for the transcription of released bacterial DNA in plant cells. Biochem. Biophys. Res. Commun., 44, 571-578.
79. Skvortsova TE, Rykova EY, Tamkovich SN, Bryzgunova OE, Starikov AV, Kuznetsova NP, Vlassov VV, Laktionov PP (2006) Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br. J. Cancer, 94, 1492-1495.
80. Bhargava PM, Shanmugam G (1971) Uptake of nonviral nucleic acids by mammalian cells. Prog. Nucleic Acid. Res. Mol. Biol., 11, 103-192.
81. Gottlieb AA (1973) Lymphoid cell RNAs and immunity. Prog. Nucleic Acid. Res. Mol. Biol., 13, 409-465.
82. Kolodny GM (1971) Evidence for transfer of macromolecular RNA between mammalian cells in culture. Exp. Cell Res., 65, 313-324.
83. Kolodny GM, Culp LA, Rosenthal LJ (1972) Secretion of RNA by normal and transformed cells. Exp. Cell Res., 73, 65-72.
84. Winston WM, Molodowitch C, Hunter CP (2002) Systemic RNAi in C. elegans requires the putative transmembrane protein SID-1. Science, 295, 2456-2459.
85. Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin RT, Mathias RT, Robinson RB, Rosen MR, Cohen IS, Brink PR (2005) Connexin-specific cell-to-cell transfer of short Interfering RNA by gap junctions. J. Physiol., 568, 459-468.
86. Saleh MC, van Rij RP, Hekele A, Gillis A, Foley E (2006) The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat. Cell Biol., 8, 793-802.
87. Kuligina EV, Vratskih OV, Semenov DV, Matveeva VA, Richter VA (2008) Deamination of adenosines in extracellular RNA spontaneously internalized by human cells. Ann. N. Y. Acad. Sci., 1137, 51-57.
88. Holdenrieder S, Burges A, Reich O, Spelsberg FW, Stieber P (2008) DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann. N. Y. Acad. Sci., 1137, 162-170.
89. Prince WS, Baker DL, Dodge AH, Ahmed AE, Chestnut RW, Sinicropi DV (1998) Pharmacodynamics of recombinant human DNase I in serum. Clin. Exp. Immunol., 113, 289-296.
90. Cherepanova AV, Tamkovich SM, Bryzgunova OE, Vlassov VV, Laktionov PP (2008) Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumours. Ann. N. Y. Acad. Sci., 1137, 218-221.
91. Tsui NB, Ng EK, Lo YM (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem., 48, 1647-1653.
92. Holford NC, Sandhu HS, Thakkar H, Butt AN, Swaminathan R (2008) Stability of ß-actin mRNA in plasma. Ann. N. Y. Acad. Sci., 1137, 108-111.
93. Reddi KK, Holland JF (1976) Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Nat. Acad. Sci. U.S.A., 73, 2308-2310.
94. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet., 62, 768-775.
95. Walton D, Nakazawa S, Kajikawa M, Naito Y, Ichikawa M, Kimoto E, Sano H, Suzuki Y, Asai T (1979) RNase levels in golden hamsters with dhpn induced pancreatic cancer. Gastroenterol. Jpn., 14, 74-79.
96. Chim SS, Tong YK, Chiu RW, Lau TK, Leung TN, Chan LY, Oudejans CB, Ding C, Lo YM (2005) Detection of the epigenetic signature of the maspin gene in maternal plasma. Proc. Natl. Acad. Sci. U.S.A., 102, 14753-14758.
97. Swaminathan R, Butt A (2006) Circulating nucleic acids in plasma and serum: recent developments. Ann. N. Y. Acad. Sci., 1075, 1-9.
98. Wong BC, Chiu RW, Tsui NB, Chan KC, Chan LW, Lau TK, Leung TN, Lo YM (2005) Circulating placental RNA in maternal plasma is associated with a preponderance of 5' mRNA fragments: Implications for noninvasive prenatal diagnosis and monitoring. Clin. Chem., 51, 1786-1795.
99. Daniels G, Finning K, Martin P, Summers J (2006) Fetal blood group genotyping. Present and future. Ann. N. Y. Acad. Sci., 1075, 88-95.
100. Chung GT, Chiu RW, Chan KC, Lau TK (2005) Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin. Chem., 51, 655-658.
101. Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn S (2005) Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin. Chem., 51, 652-655.
102. Lo YM (2008) Fetal nucleic acids in maternal plasma: toward the development of a noninvasive prenatal diagnosis of fetal chomosomal aneuploidies. Ann. N. Y. Acad. Sci., 1137, 140-143.
103. Lo YM; Lun FM; Chan KC, Tsui NB, Chong KC, Lau TK, Leung TY, Zee BC, Cantor CR, Chiu RW (2007) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc. Natl. Acad. Sci. U.S.A., 104, 13116-13121.
104. Papasavva T, Kalikas I, Kyrri A, Kleanthous M (2008) Arrayed primer extension for the noninvasive prenatal diagnosis of ß-thalassemia based on detection of single nucleotide polymorphisms. Ann. N. Y. Acad. Sci., 1137, 302-308.
105. Butt AN, Shalchi Z, Hamaoui K, Samadhan A, Powrie J, Smith S, Janikoun S, Swaminathan R (2006) Circulating nucleic acids and diabetic complications. Ann. N. Y. Acad. Sci., 1075, 258-270.
106. Shalchi Z, Sandhu HS, Butt AN, Smith S, Powrie S, Swaminathan R (2008) Retina specific mRNA in the assessment of diabetic retinopathy. Ann. N. Y. Acad. Sci., 1137, 253-257.
107. Wolf G (2005) Function of the protein RPE65 in the visual cycle. Nutr. Rev., 63, 97-100.
108. Molday RS (2007) Focus on molecules: retinoschisin (RS1). Exp. Eye Res., 84, 227-228.
109. Peirson S, Foster RG (2006) Melanopsin: another way of signaling light. Neuron, 49, 331-339.
110. Hannibal J (2006) Regulation of melanopsin expression. Chronobiol. Int., 23, 159-166.
111. Wong A, Merritt S, Butt AN, Williams A, Swaminathan R (2008) Effect of hypoxia on circulating levels of retina-specific messenger RNA in type 2 diabetes. Ann. N. Y. Acad. Sci., 1137, 243-252.
112. Sandhu HS, Butt AN, Powrie J, Swaminathan R (2008) Measurement of circulating neuron specific enolase mRNA in Diabetes Mellitus. Ann. N. Y. Acad. Sci., 1137, 258-263.
113. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW (1994) Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med., 331, 854-860.
114. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M (1998) Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin. Ther., 20, 169-181.
115. Marangos PJ, Schmechel DE (1987) Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann. Rev. Neurosci., 10, 269-295.
116. Kato K, Ishiguro Y, Suzuki F, Ito A, Semba R (1982) Distribution of nervous system-specific forms of enolase in peripheral. tissues. Brain Res., 237, 441-448.
117. Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W (1989) Clinical biochemistry of neuron specific enolase. Clin. Chim. Acta, 183, 13-31.
118. Ishiguro Y, Kato K, Ito T, Nagaya M, Yamada N, Sugito T (1983) Nervous system-specific enolase in serum as a marker for neuroblastoma. Pediatrics, 72, 696-700.
119. Toyoda M, Suzuki D, Umezono T, Uehara G, Maruyama M, Honma M, Sakai T, Sakai H (2004) Expression of human nephrin mRNA in diabetic nephropathy. Nephrol. Dial. Transplant., 19, 380-385.
120. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W (2006) Increased plasma DNA integrity index in head and neck cancer patients. Int. J. Cancer, 119, 2673-2676.
121. Boddy JL, Gal S, Malone PR, Harris AL, Wainscoat JS (2005) Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clin. Cancer Res., 11, 1394-1399.
122. Xue X, Zhu YM, Woll PA (2006) Circulating DNA and lung cancer. Ann. N. Y. Acad. Sci., 1075, 154-164.
123. Schmidt B, Weickmann S, Witt C, Fleischhacker M (2008) Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann. N. Y. Acad. Sci., 1137, 207-213.
124. Tamkovich SN, Litvjakov NV, Bryzgunova OE, Rykova EY, Dobrodeev AY, Zavjalov AA, Tusikov SA, Vlassov VV, Cherdyntseva NV, Laktionov PP (2008) Cell-surface-bound DNA as a prognostic factor in lung cancer. Ann. N. Y. Acad. Sci., 1137, 214-217.
125. Sorenson GD (2000) A review of studies on the detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Ann. N. Y. Acad. Sci., 906, 13-16.
126. Su YH, Song J, Wang Z, WangXH, Wang M, Brenner DE, Block TM (2008) Removal of high molecular weight DNA by carboxylate magnetic beads enhances the detection of mutated K-ras DNA in urine. Ann. N. Y. Acad. Sci., 1137, 82-91.
127. Ward R, Sheehan C, Norrie M, Applegate T, Fuery C, Impey H, Hawkins N, Todd A (2000) Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer. Ann. N. Y. Acad. Sci., 906, 17-18.
128. Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S, Pierotti MA (2006) Quantitative analysis of plasma DNA in colorectal cancer patients. Ann. N. Y. Acad. Sci., 1075, 185-190.
129. Schwarzenbach H, Stoehlmacher J, Pantel K, Goekkurt E (2008) Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann. N. Y. Acad. Sci., 1137, 190-196.
130. Taback B, Saha S, Hoon DS (2006) Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients. Ann. N. Y. Acad. Sci., 1075, 197-203.
131. Rykova EY, Tsvetovskaya GA, Sergeeva GI, Vlassov VV, Laktionov PP (2008) Methylation-based analysis of circulating DNA for beast tumour screening. Ann. N. Y. Acad. Sci., 1137, 232-235.
132. Bryzgunova OE, Morozkin ES, Yarmoschuk SV, Vlassov VV, Laktionov PP (2008) Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients. Ann. N. Y. Acad. Sci., 1137, 222-225.
133. Müller I, Urban K, Pantel K, Schwarztenbach H (2006) Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia. Ann. N. Y. Acad. Sci., 1075, 222-229.
134. Dasi F, Martinez-Rodes P, March JA, Santamaria J, Martinez-Javaloyas JM, Gil M, Alino SF (2006) Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann. N. Y. Acad. Sci., 1075, 204-210.
135. Lam NY, Rainer TH, Wong LK, Lam W, Lo YM (2006) Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset. Resuscitation, 68, 71-78.
136. Rainer TH, Lo YM, Chan LY, Lam NY, Lit LC, Cocks RA (2001) Derivation of a prediction rule for posttraumatic organ failure using plasma DNA and other variables. Ann. N. Y. Acad. Sci., 945, 211-220.
137. Rainer TH, Wong LK, Lam W, Yuin E, Lam NY, Metreweli C, Lo YM (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin. Chem., 49, 562-569.
138. Al Bakir M, Butt AN, Swaminathan R (2008) Circulating 11 ß-hydroxysteroid dehydrogenase Type I mRNA and cardiovascular risk factors. Ann. N. Y. Acad. Sci., 1137, 283-289.
139. Agalou S, Butt A, Chowienczyk P, Swaminathan R (2008) Hypertension and circulating mRNA for 11 ß-hydroxysteroid dehydrogenase Type II. Ann. N. Y. Acad. Sci., 1137, 290-295.
140. Thakkar H, Butt AN, Powrie J, Holt R, Swaminathan R (2008) Circulating nucleic acids in the assessment of endogenous growth hormone production. Ann. N. Y. Acad. Sci., 1137, 58-65.
141. Silva J, García V, García JM, Peña C, Domínguez G, Díaz R, Lorenzo Y, Hurtado A, Sánchez A, Bonilla F (2007) Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res., 9, R55.